Innovation Incentives: Decision Matrix

Macro Consulting Reading: For CEOs, CFOs, COOs, and SME board members in Portugal, this topic should be approached as a management decision: strategic impact, available evidence, execution risk, and internal capacity.

In March 2025, a medical device company in Porto simultaneously submitted applications to SIFIDE II and an R&D Mobilising Project. Total investment: €2.4M. SIFIDE approval: €420k in tax credit. Mobilising Project approval: €960k in non-repayable grant. The problem: the company had not mapped the accumulation rules, declared the same expenses in both instruments, and lost €280k due to ineligible overlap. The ex-post audit detected the irregularity. Result: partial repayment, penalties, and two years without access to EU incentives. This scenario is recurring in significant gains from applications that mix tax incentives and PT2030 programmes, according to data from the Portugal 2030 Managing Authority.

The innovation incentives landscape for R&D in Portugal 2026 has become technically complex. Four families of instruments—SIFIDE, national programmes (Startup Voucher, Mobilising Projects, Agendas), regional PT2030 programmes, and Horizon Europe—offer funding rates ranging from significant to highly significant, but with eligibility rules, submission calendars, and accumulation limits that require a portfolio strategy. Companies treating each application in isolation leave substantial potential funding on the table. This article provides the technical decision matrix we use at Macro Consulting® to build multi-instrument application strategies for R&D projects.

Why Innovation Incentive Strategy Determines the Financial Viability of R&D Projects

The most common conceptual error: treating business incentives as "nice to have" rather than a structural component of the financial model. In an R&D project with €1.5M investment, the difference between capturing significant or highly significant public funding can represent €450k—often the margin between viability and abandonment.

Portugal 2030 data shows that only a significant portion of Portuguese companies actively combine tax incentives with direct funding programmes. The remaining companies apply to a single instrument, usually the one they know best or that external consultants propose first. This single-instrument approach has three hidden costs:

• Structural underfunding: projects sized to the funding rate of a single programme (typically significant) when they could access higher amounts by combining instruments
• Wasted ineligible expenses: project components that do not fit one programme but would be eligible in another go unfunded
• Misaligned timing: missed application windows because the company waited for the "ideal programme" instead of sequencing complementary applications

The innovation incentives strategy for R&D in Portugal 2026 addresses this through three steps: cross-eligibility mapping (which expenses qualify under which programmes), accumulation optimisation (maximising total funding while respecting regulatory limits), and temporal sequencing (application order that maximises approval probability and minimises repayment risk).

This article is part of the broader strategy of securing European funds through a portfolio approach, focusing specifically on the R&D subfield where instrument density and rule complexity are highest.

The Four Innovation Funding Instruments: Technical Characterisation and Strategic Positioning

The R&D incentives landscape in Portugal is divided into four families with distinct operating logics. Understanding these differences is a prerequisite for building an accumulation strategy.

SIFIDE II: Tax Benefit Based on Actual R&D Expenditure

The Fiscal Incentive System for Business R&D (SIFIDE II) is not a funding programme—it is a tax credit that reduces corporate income tax (IRC) payable. Technical features:

• Base rate: 32, significant percentage of eligible R&D expenses (incremental rate of significant percentage on the increase compared to the average of the previous two years)
• Annual limit: €1.5M tax credit per company (€3M for projects contracted with entities from the scientific and technological system)
• Eligible expenses: R&D personnel, acquisition of tangible and intangible fixed assets, participation in R&D projects, audits and certification, patent registration and maintenance
• Deduction period: up to 10 years (unused tax credit in one year can be carried forward)
• Mandatory certification: ANI (National Innovation Agency) must certify that activities qualify as R&D

Strategic advantage: SIFIDE does not consume EU programme budgets and can be combined with almost all PT2030 and Horizon Europe instruments, respecting state aid limits. Disadvantage: benefit is only realised if there is sufficient taxable profit to absorb the tax credit.

Practical rule: SIFIDE works best for profitable companies with ongoing (not one-off) R&D projects and the ability to certify expenses annually. For pre-revenue startups or companies with tax losses, the benefit may take 5-8 years to materialise, reducing net present value.

National Programmes: Startup Voucher, Mobilising Projects, Mobilising Agendas

This family includes instruments managed by ANI with non-repayable funding. Three dominant programmes for R&D:

Startup Voucher (2026: estimated budget €15M):

• Support for entrepreneurs in idea validation or prototype development phase
• Amount: up to €21,500 per promoter (maximum 3 promoters = €64,500)
• Funding rate: significant non-repayable grant
• Duration: 12 months
• Eligibility: individuals without a registered company or companies less than 2 years old

Mobilising Projects for Reindustrialisation (current cycle: €180M budget):

• Business R&D projects in consortium (minimum 3 entities, including at least 1 SME)
• Minimum investment: €5M (projects up to €25M are common)
• Funding rate: significant (varies by company size and research type)
• Duration: 24-36 months
• Eligible components: industrial research, experimental development, innovation activities

Mobilising Agendas for Business Innovation (current cycle: €650M budget):

• Integrated long-term R&D programmes in strategic areas (health, mobility, agri-food, marine, etc.)
• Minimum investment: €10M (typical projects: €30-80M)
• Funding rate: significant depending on TRL (Technology Readiness Level) and company size
• Duration: 36-48 months
• Requirement: broad consortium with scientific system entities

Strategic advantage: high-rate non-repayable funding, ideal for high technological risk projects. Disadvantage: complex application process (150-300 hours preparation for Mobilising Projects), consortium requirement, and long approval times (6-9 months).

Regional PT2030 Programmes: SI Inovação and SI Investigação

Each region (North, Centre, Lisbon, Alentejo, Algarve) manages its own operational programmes with specific R&D calls. The two main instruments:

SI Inovação (Innovation Incentive System):

• Individual business R&D projects
• Investment: €175k to €5M (varies by region)
• Funding rate: significant (small companies in less developed regions reach the top rate)
• Components: industrial research, experimental development, process/organisational innovation
• Execution period: 24-36 months

SI Investigação (Co-promotion Research Incentive System):

• Consortium projects between companies and scientific entities
• Minimum investment: €500k
• Funding rate: significant (fundamental research component can reach highly significant)
• Requirement: formal partnership with university, laboratory, or technology centre
• Duration: 24-48 months

Strategic advantage: regional programmes have predictable opening calendars (usually Q1 and Q3 each year) and higher approval rates than competitive national programmes (significant vs. highly significant). Disadvantage: lower investment ceilings and requirement for project location in the region.

The full PT2030 call calendar for the current cycle shows that SI Inovação typically opens in February-March (North and Centre) and September-October (Lisbon and Alentejo), allowing for application sequencing planning.

Horizon Europe: Pillar II (Global Challenges) and European Innovation Council

European R&D programmes offer the largest grants but with international competition. Two relevant instruments for Portuguese companies:

Pillar II Clusters (e.g., Digital/Industry/Space, Climate/Energy/Mobility, Health):

• International collaborative projects (minimum 3 countries)
• Typical investment: €3M-€10M (total consortium can reach €20M)
• Funding rate: significant for industrial research, significant for experimental development (highly significant for non-profit entities)
• Duration: 36-48 months
• Requirement: consortium with at least 3 entities from 3 different countries

EIC Accelerator (European Innovation Council):

• Support for scale-ups with high-risk disruptive innovation
• Amount: up to €2.5M grant + up to €15M equity (blended instrument)
• Grant rate: significant (development and demonstration phase)
• Eligibility: SMEs with TRL 5-8 (technology validated in relevant environment)
• Process: two-stage (short application + full proposal for selected applicants)

Strategic advantage: large amounts, international prestige, access to European networks. Disadvantage: very low approval rates (significant in EIC Accelerator, significant in Clusters), intensive preparation (300-500 hours), and international consortium requirement.

Practical rule: Horizon Europe works best as a complement to national programmes, not as a first option. Companies with nationally funded projects seeking to scale up or internationalise achieve better approval rates (demonstrated prior experience).

Technical Decision Matrix: Eligibility, Accumulation, and Sequencing

Building an innovation incentives strategy for R&D in Portugal 2026 involves three sequential analyses: which expenses qualify under each programme, which combinations are permitted, and in what order to apply.

Cross-Eligibility Framework: Expense-Programme Mapping

Each instrument has its own definition of eligible expenses. The common mistake is to assume that "R&D expenses" are universally eligible—they are not. Practical example:

IoT platform development project for industrial monitoring (total investment: €1.8M):

• R&D personnel (€720k): eligible in SIFIDE (significant), SI Inovação (significant), Mobilising Projects (significant), Horizon Europe (significant)
• Laboratory equipment (€340k): eligible in SIFIDE (significant), SI Inovação (significant), Mobilising Projects (significant—asset limit), Horizon Europe (pro-rata depreciation)
• External R&D services (€280k): eligible in SIFIDE (significant), SI Inovação (significant—subcontracting limit), Mobilising Projects (significant if scientific system entity), Horizon Europe (significant)
• Patent registration (€65k): eligible in SIFIDE (significant), SI Inovação (not eligible), Mobilising Projects (eligible if part of valorisation plan), Horizon Europe (not eligible)
• Certification and testing (€180k): eligible in SIFIDE (significant), SI Inovação (significant), Mobilising Projects (significant), Horizon Europe (significant)
• Innovation marketing (€95k): not eligible in SIFIDE, eligible in SI Inovação (significant—innovation activities), eligible in Mobilising Projects (significant), not eligible in Horizon Europe
• R&D team training (€120k): not eligible in SIFIDE, eligible in SI Inovação (significant), eligible in Mobilising Projects (significant), eligible in Horizon Europe (yes, but typically not funded by consortium preference)

This mapping shows that expenses total €1.8M but eligibility varies: SIFIDE covers €1.585M, SI Inovação covers €1.625M (with limits), Mobilising Projects cover €1.705M, Horizon Europe covers €1.48M. The optimal strategy is not to apply to the programme with the broadest coverage, but to combine programmes to maximise total funding while respecting accumulation limits.

Practical tool: eligibility matrix. Build a table with expenses as rows and programmes as columns. For each cell, indicate: eligible (yes/no), maximum allowed percentage, and special conditions. This matrix becomes the input for accumulation analysis.

Accumulation Limits and State Aid Rules

European state aid regulation (GBER—General Block Exemption Regulation) defines maximum public funding limits by activity type and company size. For R&D:

Industrial Research:

• Small company: up to significant
• Medium company: up to significant
• Large company: up to significant
• Collaboration bonus: +significant if project in effective cooperation with research entities
• Dissemination bonus: +significant if results are widely disseminated

Experimental Development:

• Small company: up to significant
• Medium company: up to significant
• Large company: up to significant
• Collaboration bonus: +significant
• Dissemination bonus: +significant

These limits apply to the sum of all public aid for the same eligible expenses. Example calculation:

Small company with €1M project, significant industrial research (€600k) and significant experimental development (€400k). Maximum limits:

• Industrial research: €600k × significant = €420k (without bonus) or €600k × significant = €540k (with collaboration + dissemination)
• Experimental development: €400k × significant = €180k (without bonus) or €400k × significant = €260k (with bonus)
• Total maximum: €600k (without bonus) or €800k (with bonus)

If the company applies to SI Inovação (significant rate) and is approved: €1M × significant = €650k. This is within the bonus limit (€800k), but if they want to add SIFIDE (32, significant on the same €1M = €325k), the total would be €975k—above the limit even with bonus.

Solution: segregate expenses. Apply SI Inovação to €800k of expenses (receiving €520k at significant rate), and apply SIFIDE to the remaining €1M of expenses (receiving €325k). Total funding: €845k on €1.8M = effective significant, within limits.

Critical rule: SIFIDE counts as state aid for accumulation purposes. SIFIDE aid intensity is calculated as: (tax credit × IRC rate) / eligible expenses. With IRC at significant, a SIFIDE credit of 32, significant equates to an aid intensity of approximately 6, significant. This value is added to direct funding programmes.

Practical tool: accumulation calculator. For each programme combination, calculate:

• Programme A intensity = funding A / common eligible expenses
• Programme B intensity = funding B / common eligible expenses
• SIFIDE intensity = (tax credit × IRC rate) / common eligible expenses
• Total intensity = sum of intensities
• Check: total intensity ≤ GBER limit for activity type and company size

If total intensity exceeds the limit, reduce the amount applied for in one programme or segregate expenses into non-overlapping packages.

Temporal Sequencing: Application Order That Maximises Approval

The order of submission matters for three reasons: call opening calendars, approval dependencies (some programmes require confirmed co-funding), and risk management (diversifying timing reduces the chance of being left without funding).

Sequencing protocol in five steps:

Step 1: Map the current cycle call calendar

List all potentially relevant programmes and their expected opening dates. For the current cycle:

• SIFIDE: annual submission until May of the year following the expenses (maximum flexibility)
• SI Inovação North/Centre: typically February-March and September-October
• SI Inovação Lisbon: March-April
• Mobilising Projects: ad-hoc calls, usually Q2 (June-July)
• Mobilising Agendas: 2026 will likely have a call in Q1 for 2026-2029 execution
• Horizon Europe: continuous calls with specific deadlines per topic (see portal)

The detailed PT2030 call calendar provides confirmed and estimated dates by region.

Step 2: Identify approval dependencies

Some programmes value or require confirmed co-funding. Horizon Europe, for example, positively assesses applications where the company demonstrates the ability to finance the uncovered portion. If planning to apply to Horizon Europe (decision in 6-8 months), consider submitting SI Inovação first (decision in 3-4 months)—approval of SI Inovação strengthens financial credibility in the Horizon Europe application.

Step 3: Calculate weighted approval probability

Historical approval rates (2023-2024 data):

• SIFIDE: ~significant (provided ANI certification is obtained)
• SI Inovação: significant (varies by region and sector)
• Mobilising Projects: significant
• Agendas: significant (highly competitive)
• Horizon Europe Clusters: significant
• EIC Accelerator: significant

Portfolio strategy: do not rely on a single low-probability programme. Typical combination: SIFIDE (high probability, low amount) + SI Inovação (medium probability, medium amount) + Mobilising Project or Horizon Europe (low probability, high amount). This combination provides a base scenario (SIFIDE approved), a likely scenario (SIFIDE + SI Inovação), and an optimal scenario (all approved with expense segregation).

Step 4: Sequence applications by risk and timing

General rule: submit first to programmes with higher probability and faster decision. This creates real options:

• If SI Inovação is approved in April, you can adjust the Mobilising Project application in June (segregating expenses)
• If SI Inovação is rejected, you can broaden the scope of the Mobilising Project or Horizon Europe application
• SIFIDE is always submitted (high probability, no conflict with other applications if well structured)

Typical sequence for a project starting in the current cycle:

• January-February 2026: prepare SI Inovação application (submission in March)
• March-April 2026: prepare SIFIDE application for 2025 expenses (submission in May) and start preparing Mobilising Project
• May-June 2026: await SI Inovação decision (expected June-July), adjust Mobilising Project application
• July 2026: submit Mobilising Project if call opens
• September-October 2026: Mobilising Project decision, consider Horizon Europe application for 2027 if applicable

Step 5: Build funding scenarios

For each approval combination, calculate total funding and funding gap:

Scenario 1 (conservative): only SIFIDE approved → funding €325k on €1.8M = significant → gap €1.475M

Scenario 2 (likely): SIFIDE + SI Inovação → funding €845k = significant → gap €955k

Scenario 3 (optimal): SIFIDE + SI Inovação + Mobilising Project → funding €1.365k = significant → gap €435k

This exercise reveals whether the project is viable with only the conservative scenario (good practice) or depends on the optimal scenario (high risk). If viability depends on approval of programmes with probability <significant, consider resizing the project or seeking complementary sources (own capital, structured bank financing, or investors).

Implementation: 90-Day Roadmap to Build a Multi-Instrument Application Strategy

Preparing applications for innovation incentives for R&D in Portugal 2026 requires 8-12 weeks of technical work. Four-phase roadmap:

Weeks 1-3: Diagnosis and Eligibility Mapping

Week 1: Technical Characterisation of the Project

Document the project in a structured format:

• Technical objectives and expected results (specify initial and final TRL)
• Detailed work plan (work packages, tasks, deliverables)
• Assigned team (FTEs by function, qualifications, % dedication)
• Total investment breakdown (personnel, equipment, external services, IP, others)
• Timeline (total duration, main milestones)
• Involved partners (if applicable: universities, technology providers, pilot customers)

Output: 15-20 page technical document to serve as the basis for all applications (avoids rewriting the project from scratch for each programme).

Week 2: Programme-by-Programme Eligibility Analysis

For each potentially relevant programme, assess:

• Promoter eligibility criteria (size, sector, location, maturity)
• Project eligibility criteria (type of R&D, TRL, duration, partnership)
• Eligible expenses and limits (build expense-programme matrix)
• Applicable funding rates
• Application requirements (documentation, certifications, guarantees)

Output: shortlist of 3-5 programmes where project and promoter are eligible, with calculated funding rates.

Week 3: ANI Certification for SIFIDE

If planning to use SIFIDE, start the ANI certification process immediately. Steps:

• Register the project on the ANI portal
• Submit technical characterisation form
• Await technical analysis (15-30 days)
• Respond to clarification requests if necessary
• Obtain prior certification (valid for future expenses)

Note: ANI certification can be obtained before starting expenses, allowing early SIFIDE eligibility validation. Certification approval rate is ~significant, but significant are rejected for activities considered "standard product development" rather than genuine R&D.

Weeks 4-6: Accumulation Optimisation and Scenario Building

How to Turn the Topic into an Executive Decision

The executive utility of this topic depends on a simple question: what decision should it unlock? Management must define the problem, compare alternatives, appoint a responsible party, and choose indicators that show real progress.

In SMEs, the gap between intention and execution appears in the details: who decides, who executes, what data validates the decision, what risks are accepted, and when the team reviews results. Without this cadence, the company accumulates initiatives without learning.

This structure makes the content more useful for decision-makers and clearer for AI-based response engines: entity, audience, problem, criteria, sources, and next step are explicit.

Questions for the Board

• What concrete decision should this topic unlock?
• What internal data supports that decision?
• Who is responsible for execution and progress measurement?
• What risk increases if the company delays?
• What capacity must exist before investing?

Related Readings

• PT2030 incentives
• innovation incentives
• decarbonisation
• PT2030
• SIFIDE

Sources

For further context and validation, consult public and institutional sources relevant to this topic:

• Portugal 2030
• IAPMEI - Incentives and Funding
• ANI - SIFIDE